GSA Capital Partners »

Supernus Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $249k 7.3k 34.14
2023-12-31 $241k 8.3k 28.95
2023-09-30 $201k 7.3k 27.58
2022-12-31 $585k 16k 35.68
2022-03-31 $324k 10k 32.33
2019-12-31 $1.0M 43k 23.72
2019-09-30 $272k 9.9k 27.51
2018-12-31 $289k 8.7k 33.22
2018-06-30 $2.1M 36k 59.84
2018-03-31 $2.8M 62k 45.80
2017-12-31 $2.7M 67k 39.85
2017-09-30 $1.6M 41k 39.99
2017-06-30 $4.7M 109k 43.10
2017-03-31 $4.3M 138k 31.30
2016-12-31 $3.2M 127k 25.25
2016-09-30 $3.1M 127k 24.73
2016-06-30 $4.3M 210k 20.37
2016-03-31 $3.8M 252k 15.25
2015-12-31 $3.0M 220k 13.44
2015-09-30 $3.0M 214k 14.03
2015-06-30 $2.0M 119k 16.98